Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)NDA208775-001

ABACAVIR AND LAMIVUDINE(ABACAVIR)

Manufacturer: CIPLA LIMITED

FDA Approval: 06/04/2017

Route: ORAL · TABLET, FOR SUSPENSION

Active Ingredients

ABACAVIR 120MG; LAMIVUDINE 60MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR AND LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.